Skip to main content

Posts tagged with "Current Events"

  • Current Events

    A Brief Note on Immigration and American Science

    There’s an article out today from John Maraganore (CEO of Alnylam, immediate past chair of the BIO industry group) and his successor at BIO, Jeremy Levin (CEO of Ovid Therapeutics). They’re making the point that the current administration’s restrictions on legal immigration (real, attempted, and threatened) are a direct threat to… Read More
  • Clinical Trials

    Africa, African-Americans, and the Coronavirus Vaccines

    I mentioned yesterday in my post about anti-vaccine arguments that there seemed to be suspicions on social media platforms about vaccine testing in Africa. I’ve been looking around for more of that, and finding plenty of it. I’ve also heard from a colleague with some pertinent thoughts about how these things get going, and I… Read More
  • Current Events

    Not Winning Friends, Not Influencing People

    Many chemists will by now be aware of the brief, but very loud, incident with Angewandte Chemie and a paper by Tomas Hudlicky that appeared there. Well, it didn’t appear for long – within hours, the link had disappeared. The article appears to have been an update of parts of his book “The Way of… Read More
  • Current Events

    Surgisphere and Their Data (Updated)

    Update, and this one needs to be at the top of the page. As you will see from the additions to this post, the entire Surgisphere story has collapsed. None of their papers can now be regarded as valid – vide infra. So we have a very strange situation with some recent publications, one that… Read More
  • Current Events

    Some Commentary

    It feels strange to be writing about biomedicine, even about a terrible pandemic, under the current circumstances. I was six years old in 1968 and was thus largely spared that year’s events, so 2020 is now the year that in which I’m most fearful about what’s happening in my country. My broad political opinions make… Read More
  • Covid-19

    Taking Hydroxychloroquine (May 19 Update)

    I was not planning to revisit this topic just yet, but President Trump has forced the issue with his mention yesterday that he’s taking hydroxychloroquine. Let’s try to keep this short: does any regular reader here actually wonder what I might think about that? I know that the comments section here gets swarmed with people… Read More
  • Covid-19

    More Chinese Traditional Medicine, Unfortunately

    I mentioned the other day that what was reported as a hydroxychloroquine trial in China may well have been (or at least begun as) a trial of “traditional Chinese medicine” (TCM). It doesn’t take much digging to turn up a number of registered clinical trials for coronavirus therapy via TCM, actually. Here are a few… Read More
  • Clinical Trials

    About Remdesivir and About “Game-Changers”

    We’ve had several releases of remdesivir data, and this was not exactly one of those controlled-release formulations. No, this was more in the “chaotic mess” category, with news items coming from several sources with partial information. I decided not to blog on it until the loud banging noises stopped, and I’m glad I did, s… Read More
  • Covid-19

    Monoclonal Antibodies for the Coronavirus (Updated May 5th)

    Antibodies as a therapy Let’s have a look at what is (in my opinion) probably our best shot at a reasonably short-term targeted therapy against the COVID-19 epidemic: the possibility of using monoclonal antibodies. These can be developed more quickly than vaccines, and a lot more quickly than a new targeted small-molecule antiviral. Like ever… Read More
  • Clinical Trials

    Anti IL-6 For Coronavirus Patients: Does It Work, or Not?

    It’s been looking for some time as if these coronavirus infections need a biphasic approach to therapy – an antiviral approach earlier on, and for those in serious trouble, perhaps a shift to immune modulation as the body’s reaction to the virus starts doing even more harm. That post goes into some detail on possible… Read More